Laura Prendergast
Stock Analyst at Stifel
(4.58)
# 112
Out of 5,182 analysts
21
Total ratings
45%
Success rate
62.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $24 → $40 | $22.71 | +76.13% | 3 | Apr 27, 2026 | |
| ERAS Erasca | Maintains: Buy | $20 → $30 | $10.14 | +195.86% | 3 | Apr 27, 2026 | |
| RVMD Revolution Medicines | Reiterates: Buy | $170 → $215 | $147.90 | +45.37% | 5 | Apr 20, 2026 | |
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $14.63 | +228.09% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $8.46 | +171.87% | 1 | Feb 11, 2026 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $4.68 | +156.41% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $102.62 | +31.55% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.70 | +196.30% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $36.73 | -56.44% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $3.02 | +429.80% | 2 | Aug 14, 2024 |
Tango Therapeutics
Apr 27, 2026
Maintains: Buy
Price Target: $24 → $40
Current: $22.71
Upside: +76.13%
Erasca
Apr 27, 2026
Maintains: Buy
Price Target: $20 → $30
Current: $10.14
Upside: +195.86%
Revolution Medicines
Apr 20, 2026
Reiterates: Buy
Price Target: $170 → $215
Current: $147.90
Upside: +45.37%
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $14.63
Upside: +228.09%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $8.46
Upside: +171.87%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $4.68
Upside: +156.41%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $102.62
Upside: +31.55%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.70
Upside: +196.30%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $36.73
Upside: -56.44%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $3.02
Upside: +429.80%